Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biotech Histochem ; 92(8): 552-559, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29161153

RESUMEN

Bortezomib is a chemotherapeutic agent used to treat several cancers; however, it exhibits severe side effects in testicular tissue. We investigated the use of agomelatine to prevent testicular tissue damage caused by bortezomib. We used 36 male Sprague-Dawley rats divided randomly into six equal groups: group 1, no treatment control; group 2, agomelatine treatment only; group 3, bortezomib treatment only for 48 h; group 4, bortezomib + agomelatine treatment for 48 h; group 5, bortezomib treatment only for 72 h; and group 6, bortezomib + agomelatine treatment for 72 h. After treatments, the rats were sacrificed and testicular tissue was harvested. Lipid oxidation (LPO) and superoxide dismutase (SOD) levels in the tissues were determined using biochemical methods. Tissue samples also were examined using histopathological and immunohistochemical techniques. The LPO level was increased, while the SOD level was decreased in the bortezomib treated groups. We found that agomelatine treatment normalized LPO and SOD activities in the bortezomib treated groups. In the spermatogonia and Sertoli cells, the staining density of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and caspase 3 were decreased in the bortezomib + agomelatine groups at both 48 and 72 h compared to bortezomib only treated groups. We observed maturation arrest, basal membrane thickening, increase in inflammatory cells and connective tissue, and edema between germ cells in the bortezomib only treated groups. By contrast, normal basal membrane, less edema and more normal maturation were observed in the bortezomib + agomelatine groups at 48 and 72 h. We found that agomelatine reduced the damaging effects of bortezomib. The use of agomelatine to prevent bortezomib induced testicular tissue damage in human patients should be investigated further.


Asunto(s)
Acetamidas/farmacología , Bortezomib/toxicidad , Testículo/efectos de los fármacos , Animales , Antineoplásicos/toxicidad , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/prevención & control , Inmunohistoquímica , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas Sprague-Dawley , Estándares de Referencia , Superóxido Dismutasa/metabolismo , Testículo/patología
2.
J Laryngol Otol ; 130(7): 616-23, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27238225

RESUMEN

OBJECTIVES: To investigate the anti-inflammatory, anti-oxidative and tissue protective effects, as well as the potential therapeutic role, of alpha-lipoic acid in experimentally induced acute otitis media. METHODS: Twenty-five guinea pigs were assigned to one of five groups: a control (non-otitis) group, and otitis-induced groups treated with saline, penicillin G, alpha-lipoic acid, or alpha-lipoic acid plus penicillin G. Tissue samples were histologically analysed, and oxidative parameters in tissue samples were measured and compared between groups. RESULTS: The epithelial integrity was better preserved, and histological signs of inflammation and secretory metaplasia were decreased, in all groups compared to the saline treated otitis group. In the alpha-lipoic acid plus penicillin G treated otitis group, epithelial integrity was well preserved and histological findings of inflammation were significantly decreased compared to the saline, penicillin G and alpha-lipoic acid treated otitis groups. The most favourable oxidative parameters were observed in the control group, followed by the alpha-lipoic acid plus penicillin G treated otitis group. CONCLUSION: Alpha-lipoic acid, with its antioxidant, anti-inflammatory and tissue protective properties, may decrease the clinical sequelae and morbidity associated with acute otitis media.


Asunto(s)
Antibacterianos/farmacología , Antioxidantes/farmacología , Membrana Mucosa/efectos de los fármacos , Otitis Media , Penicilina G/farmacología , Ácido Tióctico/farmacología , Membrana Timpánica/efectos de los fármacos , Enfermedad Aguda , Animales , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Cobayas , Malondialdehído/metabolismo , Membrana Mucosa/metabolismo , Membrana Mucosa/patología , Infecciones Neumocócicas , Streptococcus pneumoniae , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Membrana Timpánica/patología
3.
Andrologia ; 48(4): 441-52, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26259852

RESUMEN

The aim of this study was to examine the effects of amlodipine (AML) in rat testicular torsion/detorsion damage. In this study, rats were divided into eight groups: (i) sham; (ii) testicular ischaemia, 2 h of ischaemia; (iii) testicular ischaemia/reperfusion (I/R), 2 h of ischaemia followed by 2 h of reperfusion; (iv) ischaemia + AML (5 mg kg(-1)) administered 30 min before ischaemia; (v) ischaemia + AML (10 mg kg(-1)) administered 30 min before ischaemia; (vi) and (vii) I/R + AML (5 mg kg(-1)) and I/R + AML (10 mg kg(-1)) administered 1.5 h after the induction of ischaemia, respectively, and at the end of a 2-h ischaemia period and a 2-h reperfusion period applied; and (viii) sham + AML (10 mg kg(-1)). Significant decreases in levels of superoxide dismutase and glutathione were observed in ischaemia and reperfusion groups when compared with healthy controls. These antioxidant levels increased in AML groups while malondialdehyde levels significantly decreased. While increases in tumour necrosis factor-alpha and transforming growth factor-beta levels were found in the torsion and detorsion groups, significant decreases in the levels of these inflammatory cytokines were observed in the treatment groups. These results demonstrate that AML significantly produced protective effects on testis tissue damage that occurs in the torsion/detorsion model via biochemical, histopathological and molecular pathways.


Asunto(s)
Amlodipino/farmacología , Bloqueadores de los Canales de Calcio/farmacología , Daño por Reperfusión/tratamiento farmacológico , Torsión del Cordón Espermático/tratamiento farmacológico , Testículo/efectos de los fármacos , Administración Oral , Amlodipino/administración & dosificación , Animales , Antioxidantes/análisis , Antioxidantes/metabolismo , Bloqueadores de los Canales de Calcio/administración & dosificación , Glutatión/análisis , Glutatión/metabolismo , Humanos , Masculino , Malondialdehído/análisis , Malondialdehído/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Torsión del Cordón Espermático/metabolismo , Superóxido Dismutasa/análisis , Superóxido Dismutasa/metabolismo , Testículo/metabolismo , Testículo/patología , Factor de Necrosis Tumoral alfa/análisis
4.
Gynecol Endocrinol ; 28(3): 228-33, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21823905

RESUMEN

Oxidative stress is one of the main reasons of both menopause and diabetes. So, it plays crucial role in the pathogeneses of that condition and disease. Therefore, the objective of the present study was to investigate the effects of menopause and diabetes upon the hippocampus using a rat model. Adult female Sprague Dawley rats (n = 24) were allocated randomly as follows; control (C group) ovariectomized (O group), diabetic (D group) and ovariectomy plus diabetic groups (DO group) (n = 6; in each group), respectively. For evaluating the results, tissue biochemistry and stereological analysis were made. Biochemistry results (lipid peroxidase (LPO); catalase (CAT); superoxide dismutase (SOD); total glutatyon (GSH); and myeloperoxidase (MPO) values) in Group C-DO were determined as 12.27, 21.88, 23.08 and 29.90 nmol/gr tissue; 59.3, 70.06, 69.7 and 78.1 mmol/min/mg tissue; 174.2, 156.4, 159.7 and 154.6 mmol/min/mg tissue; 3.63, 3.61, 4.21 and 3.97 nmol/mg tissue; and 5.05, 5.68, 5.58 and 6.19 µmol/min/mg tissue, respectively. Moreover, both menopause and diabetes led to change of lipid profiles. There were significant differences between the control and other groups (Group C and D-DO) (p < 0.01) and among experimental groups (p < 0.01) in terms of neuron number. When the volumes of the hippocampus were compared, there were no significant differences between the all groups (P > 0.05). At this point, we suggested that diabetes could aggravate deleterious effects of ovariectomy.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Hipocampo/química , Hipocampo/patología , Ovariectomía , Animales , Catalasa/análisis , Recuento de Células , Diabetes Mellitus Experimental/sangre , Femenino , Glutatión/análisis , Hipocampo/enzimología , Lípidos/sangre , Neuronas/patología , Estrés Oxidativo , Peroxidasa/análisis , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/análisis
5.
Am J Respir Crit Care Med ; 161(3 Pt 1): 872-9, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10712336

RESUMEN

We performed a prospective study in the 28 multidisciplinary intensive care units (ICUs) in the Rhône-Alpes area in France to investigate the role of initial versus delayed occurrence of acute renal failure (ARF) in patient outcome. ARF was defined as a serum creatinine concentration > 300 micromol/L, urine output < 500 ml/24 h (or < 180 ml/8 h), or hemodialysis requirement. Over the 1-yr study period, 1,086 patients presented with ARF on ICU admission or during the first 2 d of ICU stay (Group A; 736 patients), from Day 3 to Day 6 (Group B; 202 patients), or from Day 7 (Group C; 148 patients). The overall hospital mortality rate was 66% (61% in Group A, 71% in Group B, and 81% in Group C; p < 0.0001). Logistic regression analysis of a random sample of 510 patients showed that SAPS II score on ICU admission, number of ARF episodes, previous health status, absence of oliguria, absence of hemodialysis, and absence of ischemic acute tubular necrosis were predictive of patient survival. This model was tested and validated on the basis of the remaining patients. Thus, in this population, late ARF was not a predictive factor for patient outcome.


Asunto(s)
Lesión Renal Aguda/mortalidad , Cuidados Críticos/estadística & datos numéricos , Lesión Renal Aguda/etiología , Adulto , Anciano , Anciano de 80 o más Años , Causas de Muerte , Femenino , Francia/epidemiología , Mortalidad Hospitalaria , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA